Trial intelligence / Profile preview

CBT Via Telehealth + Amitriptyline vs CBT Alone for Pediatric Migraine Prevention

NCT05889624Recruiting

Sponsor
Cincinnati Children's Hospital Medical Center
Start
Aug 2023
Primary completion
Jul 2027
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of amitriptyline in migraine (2 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoints: Change in number of headache days and Reduction to a PedMIDAS score of 20 or less. Started Aug 2023; status: recruiting.

02

Drugs

amitriptyline
03

Conditions

migraine

Beyond the preview

Go deeper on NCT05889624.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05889624.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call